Skip to main content
Top

Open Access 03-02-2025 | Keratitis | ORIGINAL RESEARCH

Use of an Eyelid Pressure Patch Concomitantly with a Decellularized Dehydrated Amniotic Membrane for Ocular Surface Disease Management

Author: Kyle Linsey

Published in: Ophthalmology and Therapy

Login to get access

Abstract

Introduction

Persistent corneal epithelial defects (PCEDs) occur when conditions like dry eye disease (DED), neurotrophic keratitis (NK), and limbal stem cell deficiency impair corneal healing, leading to risks of infection, scarring, or perforation. Decellularized, dehydrated pure amniotic membrane basement membrane (AMBM) supports healing by promoting cell adhesion, growth, and inflammation reduction. Eyelid pressure patching helps stabilize the AMBM, protects the cornea, and enhances its therapeutic effects.

Methods

This retrospective study analyzed 144 eyes treated with either a single-layer or three-layer decellularized AMBM combined with a 24-h eyelid pressure patch.

Results

Of the patients included, 90% received a single-layer AMBM and 10% a three-layer AMBM. In the single-layer group, 100% of cases showed complete healing and AMBM dissolution. In the three-layer group, 100% showed corneal staining improvement, but 20–30% of the AMBM remained undissolved. No patients reported experiencing pain, discomfort, or infection.

Conclusions

Combining eyelid pressure patching with amniotic membrane treatment is a safe and effective approach for healing persistent corneal epithelial defects.
Appendix
Available only for authorised users
Literature
1.
go back to reference Leong Y-Y, Tong L. Barrier function in the ocular surface: from conventional paradigms to new opportunities. Ocul Surf. 2015;13:103–9.PubMedCrossRef Leong Y-Y, Tong L. Barrier function in the ocular surface: from conventional paradigms to new opportunities. Ocul Surf. 2015;13:103–9.PubMedCrossRef
2.
3.
go back to reference Maqsood S, Elsawah K, Dhillon N, Soliman S, Laginaf M, Lodhia V, et al. Management of persistent corneal epithelial defects with human amniotic membrane-derived dry matrix. Clin Ophthalmol. 2021;28:2231–8.CrossRef Maqsood S, Elsawah K, Dhillon N, Soliman S, Laginaf M, Lodhia V, et al. Management of persistent corneal epithelial defects with human amniotic membrane-derived dry matrix. Clin Ophthalmol. 2021;28:2231–8.CrossRef
6.
go back to reference Rodríguez Calvo-de-Mora M, Domínguez-Ruiz C, Barrero-Sojo F, Rodríguez-Moreno G, Antúnez Rodríguez C, Ponce Verdugo L, et al. Autologous versus allogeneic versus umbilical cord sera for the treatment of severe dry eye disease: a double-blind randomized clinical trial. Acta Ophthalmol. 2022;100:e396–408.PubMedCrossRef Rodríguez Calvo-de-Mora M, Domínguez-Ruiz C, Barrero-Sojo F, Rodríguez-Moreno G, Antúnez Rodríguez C, Ponce Verdugo L, et al. Autologous versus allogeneic versus umbilical cord sera for the treatment of severe dry eye disease: a double-blind randomized clinical trial. Acta Ophthalmol. 2022;100:e396–408.PubMedCrossRef
7.
go back to reference Sánchez-González JM, Alonso-Aliste F, Borroni D, Amián-Cordero J, De-Hita-Cantalejo C, Capote-Puente R, Bautista-Llamas MJ, Sánchez-González MC, Rodríguez-Calvo-de-Mora M, Rocha-de-Lossada C. Plasma rich in growth factors (PRGF) in transepithelial photorefractive keratectomy (TPRK). J Clin Med. 2021;10:1939.PubMedPubMedCentralCrossRef Sánchez-González JM, Alonso-Aliste F, Borroni D, Amián-Cordero J, De-Hita-Cantalejo C, Capote-Puente R, Bautista-Llamas MJ, Sánchez-González MC, Rodríguez-Calvo-de-Mora M, Rocha-de-Lossada C. Plasma rich in growth factors (PRGF) in transepithelial photorefractive keratectomy (TPRK). J Clin Med. 2021;10:1939.PubMedPubMedCentralCrossRef
8.
go back to reference Fernandes M, Sridhar MS, Sangwan VS, et al. Amniotic membrane transplantation for ocular surface reconstruction. Cornea. 2005;24:643–53.PubMedCrossRef Fernandes M, Sridhar MS, Sangwan VS, et al. Amniotic membrane transplantation for ocular surface reconstruction. Cornea. 2005;24:643–53.PubMedCrossRef
9.
go back to reference Prabhasawat P, Tesavibul N, Komolsuradej W. Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation. Br J Ophthalmol. 2001;85:1455–63.PubMedPubMedCentralCrossRef Prabhasawat P, Tesavibul N, Komolsuradej W. Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation. Br J Ophthalmol. 2001;85:1455–63.PubMedPubMedCentralCrossRef
10.
go back to reference Letko E, Stechschulte SU, Kenyon KR, et al. Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch Ophthalmol. 2001;119:659–63.PubMedCrossRef Letko E, Stechschulte SU, Kenyon KR, et al. Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch Ophthalmol. 2001;119:659–63.PubMedCrossRef
13.
go back to reference Meller D, Pauklin M, Thomasen H, Westekemper H, Steuhl KP. Amniotic membrane transplantation in the human eye. Dtsch Arztebl Int. 2011;108:243–8.PubMedPubMedCentral Meller D, Pauklin M, Thomasen H, Westekemper H, Steuhl KP. Amniotic membrane transplantation in the human eye. Dtsch Arztebl Int. 2011;108:243–8.PubMedPubMedCentral
14.
go back to reference Sell S, de la Presa M, Thakur S, Eslani M, Jeffrey J, Sheppard JD, Holland EJ, Cheung AY. Comparison of persistent epithelial defect treatment with sutureless cryopreserved and dehydrated amniotic membrane. Am J Ophthalmol. 2023;251:32–42.PubMedCrossRef Sell S, de la Presa M, Thakur S, Eslani M, Jeffrey J, Sheppard JD, Holland EJ, Cheung AY. Comparison of persistent epithelial defect treatment with sutureless cryopreserved and dehydrated amniotic membrane. Am J Ophthalmol. 2023;251:32–42.PubMedCrossRef
15.
go back to reference Füst A, Pállinger E, Stündl A, Kovács E, Imre L, Tóth S, Németh J. Both freshly prepared and frozen-stored amniotic membrane cells express the complement inhibitor CD59. ScientificWorldJournal. 2012;2012: 815615.PubMedPubMedCentralCrossRef Füst A, Pállinger E, Stündl A, Kovács E, Imre L, Tóth S, Németh J. Both freshly prepared and frozen-stored amniotic membrane cells express the complement inhibitor CD59. ScientificWorldJournal. 2012;2012: 815615.PubMedPubMedCentralCrossRef
16.
go back to reference Walkden A. Amniotic membrane transplantation in ophthalmology: an updated perspective. Clin Ophthalmol. 2020;22(14):2057–72.CrossRef Walkden A. Amniotic membrane transplantation in ophthalmology: an updated perspective. Clin Ophthalmol. 2020;22(14):2057–72.CrossRef
17.
go back to reference Pogozhykh O, Hofmann N, Gryshkov O, von Kaisenberg C, Mueller M, et al. Repeated freezing procedures preserve structural and functional properties of amniotic membrane for application in ophthalmology. Int J Mol Sci. 2020;21:4029.PubMedPubMedCentralCrossRef Pogozhykh O, Hofmann N, Gryshkov O, von Kaisenberg C, Mueller M, et al. Repeated freezing procedures preserve structural and functional properties of amniotic membrane for application in ophthalmology. Int J Mol Sci. 2020;21:4029.PubMedPubMedCentralCrossRef
19.
go back to reference Burman S, Tejwani S, Vemuganti GK, et al. Ophthalmic applications of preserved human amniotic membrane: a review of current indications. Cell Tissue Bank. 2004;5:161–75.PubMedCrossRef Burman S, Tejwani S, Vemuganti GK, et al. Ophthalmic applications of preserved human amniotic membrane: a review of current indications. Cell Tissue Bank. 2004;5:161–75.PubMedCrossRef
20.
go back to reference Thiex NW, Chames MC, Loch-Caruso RK. Tissue-specific cytokine release from human extra-placental membranes stimulated by lipopolysaccharide in a two-compartment tissue culture system. Reprod Biol Endocrinol. 2009;7:117.PubMedPubMedCentralCrossRef Thiex NW, Chames MC, Loch-Caruso RK. Tissue-specific cytokine release from human extra-placental membranes stimulated by lipopolysaccharide in a two-compartment tissue culture system. Reprod Biol Endocrinol. 2009;7:117.PubMedPubMedCentralCrossRef
21.
22.
go back to reference Turkoglu E, Celik E, Alagoz G. A comparison of the efficacy of autologous serum eye drops with amniotic membrane transplantation in neurotrophic keratitis. Semin Ophthalmol. 2014;29:119–26.PubMedCrossRef Turkoglu E, Celik E, Alagoz G. A comparison of the efficacy of autologous serum eye drops with amniotic membrane transplantation in neurotrophic keratitis. Semin Ophthalmol. 2014;29:119–26.PubMedCrossRef
23.
go back to reference Lacorzana J, Campos A, Brocal-Sánchez M, et al. Visual acuity and number of amniotic membrane layers as indicators of efficacy in amniotic membrane transplantation for corneal ulcers: a multicenter study. J Clin Med. 2021;10:3234.PubMedPubMedCentralCrossRef Lacorzana J, Campos A, Brocal-Sánchez M, et al. Visual acuity and number of amniotic membrane layers as indicators of efficacy in amniotic membrane transplantation for corneal ulcers: a multicenter study. J Clin Med. 2021;10:3234.PubMedPubMedCentralCrossRef
24.
go back to reference Yin HY, Cheng AMS, Tighe S, et al. Self-retained cryopreserved amniotic membrane for treating severe corneal ulcers: a comparative, retrospective control study. Sci Rep. 2020;10:17008.PubMedPubMedCentralCrossRef Yin HY, Cheng AMS, Tighe S, et al. Self-retained cryopreserved amniotic membrane for treating severe corneal ulcers: a comparative, retrospective control study. Sci Rep. 2020;10:17008.PubMedPubMedCentralCrossRef
25.
go back to reference Sangwan VS, Burman S, Tejwani S, Mahesh SP, Murthy R. Amniotic membrane transplantation: a review of current indications in the management of ophthalmic disorders. Indian J Ophthalmol. 2007;55:251–60.PubMedCrossRef Sangwan VS, Burman S, Tejwani S, Mahesh SP, Murthy R. Amniotic membrane transplantation: a review of current indications in the management of ophthalmic disorders. Indian J Ophthalmol. 2007;55:251–60.PubMedCrossRef
26.
27.
go back to reference Kobayashi N, Kabuyama Y, Sasaki S, Kato K, Homma Y. Suppression of corneal neovascularization by culture supernatant of human amniotic cells. Cornea. 2002;21:62–7.PubMedCrossRef Kobayashi N, Kabuyama Y, Sasaki S, Kato K, Homma Y. Suppression of corneal neovascularization by culture supernatant of human amniotic cells. Cornea. 2002;21:62–7.PubMedCrossRef
28.
go back to reference Solomon A, Wajngarten M, Alviano F, et al. Suppression of inflammatory and fibrotic responses in allergic inflammation by the amniotic membrane stromal matrix. Clin Exp Allergy. 2005;35:941–8.PubMedCrossRef Solomon A, Wajngarten M, Alviano F, et al. Suppression of inflammatory and fibrotic responses in allergic inflammation by the amniotic membrane stromal matrix. Clin Exp Allergy. 2005;35:941–8.PubMedCrossRef
29.
go back to reference Tseng SC, Espana EM, Kawakita T, et al. How does amniotic membrane work? Ocul Surf. 2004;2:177–87.PubMedCrossRef Tseng SC, Espana EM, Kawakita T, et al. How does amniotic membrane work? Ocul Surf. 2004;2:177–87.PubMedCrossRef
30.
go back to reference Hopkinson A, Shanmuganathan VA, Gray T, et al. Optimization of amniotic membrane (AM) denuding for tissue engineering. Tissue Eng Part C Methods. 2008;14:371–81.PubMedCrossRef Hopkinson A, Shanmuganathan VA, Gray T, et al. Optimization of amniotic membrane (AM) denuding for tissue engineering. Tissue Eng Part C Methods. 2008;14:371–81.PubMedCrossRef
31.
go back to reference Mao Y, Protzman NM, John N, Kuehn A, Long D, Sivalenka R, Junka RA, Shah AU, Gosiewska A, Hariri RJ, Brigido SA. An in vitro comparison of human corneal epithelial cell activity and inflammatory response on differently designed ocular amniotic membranes and a clinical case study. J Biomed Mater Res B Appl Biomater. 2023;111:684–700.PubMedCrossRef Mao Y, Protzman NM, John N, Kuehn A, Long D, Sivalenka R, Junka RA, Shah AU, Gosiewska A, Hariri RJ, Brigido SA. An in vitro comparison of human corneal epithelial cell activity and inflammatory response on differently designed ocular amniotic membranes and a clinical case study. J Biomed Mater Res B Appl Biomater. 2023;111:684–700.PubMedCrossRef
32.
go back to reference Fukuda K, Chikama T, Nakamura M, Nishida T. Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva. Cornea. 1999;18:73–9.PubMedCrossRef Fukuda K, Chikama T, Nakamura M, Nishida T. Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva. Cornea. 1999;18:73–9.PubMedCrossRef
33.
go back to reference Endo K, Nakamura T, Kawasaki S, Kinoshita S. Human amniotic membrane, like corneal epithelial basement membrane, manifests the alpha5 chain of type IV collagen. Invest Ophthalmol Vis Sci. 2004;45:1771–4.PubMedCrossRef Endo K, Nakamura T, Kawasaki S, Kinoshita S. Human amniotic membrane, like corneal epithelial basement membrane, manifests the alpha5 chain of type IV collagen. Invest Ophthalmol Vis Sci. 2004;45:1771–4.PubMedCrossRef
34.
go back to reference Nakamura T, Yoshitani M, Rigby H, et al. Sterilized, freeze-dried amniotic membrane: a useful substrate for ocular surface reconstruction. Investig Ophthalmol Vis Sci. 2004;45:93–9.CrossRef Nakamura T, Yoshitani M, Rigby H, et al. Sterilized, freeze-dried amniotic membrane: a useful substrate for ocular surface reconstruction. Investig Ophthalmol Vis Sci. 2004;45:93–9.CrossRef
35.
go back to reference Nakamura T, Sekiyama E, Takaoka M, et al. The use of trehalosetreated freeze-dried amniotic membrane for ocular surface reconstruction. Biomaterials. 2008;29:3729–37.PubMedCrossRef Nakamura T, Sekiyama E, Takaoka M, et al. The use of trehalosetreated freeze-dried amniotic membrane for ocular surface reconstruction. Biomaterials. 2008;29:3729–37.PubMedCrossRef
36.
go back to reference Grueterich M, Tseng SC. Human limbal progenitor cells expanded on intact amniotic membrane ex vivo. Arch Ophthalmol. 2002;120:783–90.PubMedCrossRef Grueterich M, Tseng SC. Human limbal progenitor cells expanded on intact amniotic membrane ex vivo. Arch Ophthalmol. 2002;120:783–90.PubMedCrossRef
37.
go back to reference Meller D, Tseng SC. Conjunctival epithelial cell differentiation on amniotic membrane. Invest Ophthalmol Vis Sci. 1999;40:878–86.PubMed Meller D, Tseng SC. Conjunctival epithelial cell differentiation on amniotic membrane. Invest Ophthalmol Vis Sci. 1999;40:878–86.PubMed
38.
go back to reference Choi CM, Jeon HS. Clinical outcomes of in-office sutureless amniotic membrane transplantation in persistent epithelial defect. Korean J Ophthalmol. 2022;36:87–96.PubMedCrossRef Choi CM, Jeon HS. Clinical outcomes of in-office sutureless amniotic membrane transplantation in persistent epithelial defect. Korean J Ophthalmol. 2022;36:87–96.PubMedCrossRef
39.
go back to reference Cosar CB, Cohen EJ, Rapuano CJ, et al. Tarsorrhaphy: clinical experience from a cornea practice. Cornea J Cornea Extern Dis. 2001;20:787–91. Cosar CB, Cohen EJ, Rapuano CJ, et al. Tarsorrhaphy: clinical experience from a cornea practice. Cornea J Cornea Extern Dis. 2001;20:787–91.
40.
go back to reference Kasaee A, Musavi MR, Tabatabaie SV, et al. Evaluation of efficacy and safety of botulinum toxin type A injection in patients requiring temporary tarsorrhaphy to improve corneal epithelial defects. Int J Ophthalmol. 2010;3:237–40.PubMedPubMedCentral Kasaee A, Musavi MR, Tabatabaie SV, et al. Evaluation of efficacy and safety of botulinum toxin type A injection in patients requiring temporary tarsorrhaphy to improve corneal epithelial defects. Int J Ophthalmol. 2010;3:237–40.PubMedPubMedCentral
41.
go back to reference Meduri A, Valastro A, Inferrera L, Oliverio GW, Ninotta I, Camellin U, Mancini M, Roszkowska AM, Aragona P. Sutureless amniotic membrane transplantation in inflammatory corneal perforations. Appl Sci. 2022;12:3924.CrossRef Meduri A, Valastro A, Inferrera L, Oliverio GW, Ninotta I, Camellin U, Mancini M, Roszkowska AM, Aragona P. Sutureless amniotic membrane transplantation in inflammatory corneal perforations. Appl Sci. 2022;12:3924.CrossRef
42.
go back to reference Mofidfar M, Abdi B, Ahadian S, Mostafavi E, Desai TA, Abbasi F, Sun Y, Manche EE, Ta CN, Flowers CW. Drug delivery to the anterior segment of the eye: a review of current and future treatment strategies. Int J Pharm. 2021;25(607): 120924.CrossRef Mofidfar M, Abdi B, Ahadian S, Mostafavi E, Desai TA, Abbasi F, Sun Y, Manche EE, Ta CN, Flowers CW. Drug delivery to the anterior segment of the eye: a review of current and future treatment strategies. Int J Pharm. 2021;25(607): 120924.CrossRef
43.
go back to reference Travé-Huarte S, Wolffsohn JS. Bilateral sutureless application of human dehydrated amniotic membrane with a specialised bandage contact lens for moderate-to-severe dry eye disease: a prospective study with 1-month follow-up. Clin Ophthalmol. 2024;13(18):1329–39.CrossRef Travé-Huarte S, Wolffsohn JS. Bilateral sutureless application of human dehydrated amniotic membrane with a specialised bandage contact lens for moderate-to-severe dry eye disease: a prospective study with 1-month follow-up. Clin Ophthalmol. 2024;13(18):1329–39.CrossRef
44.
go back to reference Prasher P, Di Pascuale MA, et al. Evaluation of the role of ProKera in the management of ocular surface and orbital disorders. Eye Contact Lens. 2009;35:172–5.PubMedCrossRef Prasher P, Di Pascuale MA, et al. Evaluation of the role of ProKera in the management of ocular surface and orbital disorders. Eye Contact Lens. 2009;35:172–5.PubMedCrossRef
45.
go back to reference Pachigolla G, Prasher P, Di Pascuale MA, et al. Evaluation of the role of ProKera in the management of ocular surface and orbital disorders. Eye Contact Lens. 2009;35:172–5.PubMedCrossRef Pachigolla G, Prasher P, Di Pascuale MA, et al. Evaluation of the role of ProKera in the management of ocular surface and orbital disorders. Eye Contact Lens. 2009;35:172–5.PubMedCrossRef
46.
go back to reference Giannikas C, Udell IJ, Steiner A, et al. Sutureless amniotic membrane transplantation for ocular surface disorders: a comparison of Prokera to AmbioDisc. Invest Ophthalmol Vis Sci. 2014;55:4707. Giannikas C, Udell IJ, Steiner A, et al. Sutureless amniotic membrane transplantation for ocular surface disorders: a comparison of Prokera to AmbioDisc. Invest Ophthalmol Vis Sci. 2014;55:4707.
47.
go back to reference Huang Y, Sheha H, Tseng SCG. Self-retained amniotic membrane for recurrent corneal erosion. J Clin Exp Ophthalmol. 2013;4:272. Huang Y, Sheha H, Tseng SCG. Self-retained amniotic membrane for recurrent corneal erosion. J Clin Exp Ophthalmol. 2013;4:272.
48.
go back to reference Tseng SCG. Letter to the editor: PROKERA® slim corneal bandage now approved in Taiwan for treatment of corneal diseases. Taiwan J Ophthalmol. 2020;11:202–3.PubMedPubMedCentralCrossRef Tseng SCG. Letter to the editor: PROKERA® slim corneal bandage now approved in Taiwan for treatment of corneal diseases. Taiwan J Ophthalmol. 2020;11:202–3.PubMedPubMedCentralCrossRef
49.
go back to reference Chaudhary S, Ghimire D, Basu S, Agrawal V, Jacobs DS, Shanbhag SS. Contact lenses in dry eye disease and associated ocular surface disorders. Indian J Ophthalmol. 2023;71:1142–53.PubMedPubMedCentralCrossRef Chaudhary S, Ghimire D, Basu S, Agrawal V, Jacobs DS, Shanbhag SS. Contact lenses in dry eye disease and associated ocular surface disorders. Indian J Ophthalmol. 2023;71:1142–53.PubMedPubMedCentralCrossRef
50.
go back to reference Blackmore SJ. The use of contact lenses in the treatment of persistent epithelial defects. Cont Lens Anterior Eye. 2010;33:239–44.PubMedCrossRef Blackmore SJ. The use of contact lenses in the treatment of persistent epithelial defects. Cont Lens Anterior Eye. 2010;33:239–44.PubMedCrossRef
51.
go back to reference Begley CG, Caffery B, Nichols KK, Chalmers R. Responses of contact lens wearers to a dry eye survey. Optom Vis Sci. 2000;77:40–6.PubMedCrossRef Begley CG, Caffery B, Nichols KK, Chalmers R. Responses of contact lens wearers to a dry eye survey. Optom Vis Sci. 2000;77:40–6.PubMedCrossRef
52.
go back to reference Begley CG, Chalmers RL, Mitchell GL, et al. Characterization of ocular surface symptoms from optometric practices in North America. Cornea. 2001;20:610–8.PubMedCrossRef Begley CG, Chalmers RL, Mitchell GL, et al. Characterization of ocular surface symptoms from optometric practices in North America. Cornea. 2001;20:610–8.PubMedCrossRef
53.
go back to reference Doughty MJ, Fonn D, Richter D, et al. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci. 1997;74:624–31.PubMedCrossRef Doughty MJ, Fonn D, Richter D, et al. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci. 1997;74:624–31.PubMedCrossRef
54.
go back to reference Nichols JJ, Mitchell GL, Nichols KK, et al. The performance of the contact lens dry eye questionnaire as a screening survey for contact lens-related dry eye. Cornea. 2002;21:469–75.PubMedCrossRef Nichols JJ, Mitchell GL, Nichols KK, et al. The performance of the contact lens dry eye questionnaire as a screening survey for contact lens-related dry eye. Cornea. 2002;21:469–75.PubMedCrossRef
55.
go back to reference Nichols JJ, Ziegler C, Mitchell GL, Nichols KK. Self-reported dry eye disease across refractive modalities. Investig Ophthalmol Vis Sci. 2005;46:1911–4.CrossRef Nichols JJ, Ziegler C, Mitchell GL, Nichols KK. Self-reported dry eye disease across refractive modalities. Investig Ophthalmol Vis Sci. 2005;46:1911–4.CrossRef
56.
go back to reference Pritchard N, Fonn D. Dehydration, lens movement and dryness ratings of hydrogel contact lenses. Ophthalmic Physiol Opt. 1995;15:281–6.PubMedCrossRef Pritchard N, Fonn D. Dehydration, lens movement and dryness ratings of hydrogel contact lenses. Ophthalmic Physiol Opt. 1995;15:281–6.PubMedCrossRef
57.
go back to reference Richdale K, Sinnott LT, Skadahl E, Nichols JJ. Frequency of and factors associated with contact lens dissatisfaction and discontinuation. Cornea. 2007;26:168–74.PubMedCrossRef Richdale K, Sinnott LT, Skadahl E, Nichols JJ. Frequency of and factors associated with contact lens dissatisfaction and discontinuation. Cornea. 2007;26:168–74.PubMedCrossRef
58.
go back to reference Schlanger JL. A study of contact lens failures. J Am Optom Assoc. 1993;64:220–4.PubMed Schlanger JL. A study of contact lens failures. J Am Optom Assoc. 1993;64:220–4.PubMed
59.
go back to reference Young G, Veys J, Pritchard N, Coleman S. A multi-centre study of lapsed contact lens wearers. Ophthalmic Physiol Opt. 2002;22:516–27.PubMedCrossRef Young G, Veys J, Pritchard N, Coleman S. A multi-centre study of lapsed contact lens wearers. Ophthalmic Physiol Opt. 2002;22:516–27.PubMedCrossRef
60.
go back to reference Milner MS, Beckman KA, Luchs JI, Allen QB, Awdeh RM, Berdahl J, et al. Dysfunctional tear syndrome: dry eye disease and associated tear film disorders—new strategies for diagnosis and treatment. Curr Opin Ophthalmol. 2017;27:3–47.PubMedCrossRef Milner MS, Beckman KA, Luchs JI, Allen QB, Awdeh RM, Berdahl J, et al. Dysfunctional tear syndrome: dry eye disease and associated tear film disorders—new strategies for diagnosis and treatment. Curr Opin Ophthalmol. 2017;27:3–47.PubMedCrossRef
61.
go back to reference Zimmerman AB, Nixon AD, Rueff EM. Contact lens associated microbial keratitis: practical considerations for the optometrist. Clin Optom (Auckl). 2016;8:1–12.PubMed Zimmerman AB, Nixon AD, Rueff EM. Contact lens associated microbial keratitis: practical considerations for the optometrist. Clin Optom (Auckl). 2016;8:1–12.PubMed
62.
go back to reference Stapleton F. Contact lens-related microbial keratitis: what can epidemiologic studies tell us? Eye Contact Lens. 2003;29:S85–9 (discussion S115–8, S92-4).PubMedCrossRef Stapleton F. Contact lens-related microbial keratitis: what can epidemiologic studies tell us? Eye Contact Lens. 2003;29:S85–9 (discussion S115–8, S92-4).PubMedCrossRef
63.
go back to reference MacRae S, Herman C, Stulting RD, et al. Corneal ulcer and adverse reaction rates in premarket contact lens studies. Am J Ophthalmol. 1991;111:457–65.PubMedCrossRef MacRae S, Herman C, Stulting RD, et al. Corneal ulcer and adverse reaction rates in premarket contact lens studies. Am J Ophthalmol. 1991;111:457–65.PubMedCrossRef
64.
go back to reference Tam C, Mun JJ, Evans DJ, Fleiszig SM. The impact of inoculation parameters on the pathogenesis of contact lens-related infectious keratitis. Invest Ophthalmol Vis Sci. 2010;51:3100–6.PubMedPubMedCentralCrossRef Tam C, Mun JJ, Evans DJ, Fleiszig SM. The impact of inoculation parameters on the pathogenesis of contact lens-related infectious keratitis. Invest Ophthalmol Vis Sci. 2010;51:3100–6.PubMedPubMedCentralCrossRef
65.
go back to reference Fleiszig SM. The Glenn A. Fry award lecture 2005. The pathogenesis of contact lens-related keratitis. Optom Vis Sci. 2006;83:866–73.PubMedCrossRef Fleiszig SM. The Glenn A. Fry award lecture 2005. The pathogenesis of contact lens-related keratitis. Optom Vis Sci. 2006;83:866–73.PubMedCrossRef
66.
go back to reference Alarcon I, Tam C, Mun JJ, et al. Factors impacting corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Investig Ophthalmol Vis Sci. 2011;52:1368–77.CrossRef Alarcon I, Tam C, Mun JJ, et al. Factors impacting corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Investig Ophthalmol Vis Sci. 2011;52:1368–77.CrossRef
67.
go back to reference Stapleton F, Keay L, Edwards K, et al. The incidence of contact lens–related microbial keratitis in Australia. Ophthalmology. 2008;115:1655–62.PubMedCrossRef Stapleton F, Keay L, Edwards K, et al. The incidence of contact lens–related microbial keratitis in Australia. Ophthalmology. 2008;115:1655–62.PubMedCrossRef
68.
go back to reference Liesegang TJ. Contact lens–related microbial keratitis: part I: epidemiology. Cornea. 1997;16:125–31.PubMed Liesegang TJ. Contact lens–related microbial keratitis: part I: epidemiology. Cornea. 1997;16:125–31.PubMed
69.
go back to reference Schein OD, Buehler PO, Stamler JF, et al. The impact of overnight wear on the risk of contact lens–associated ulcerative keratitis. Arch Ophthalmol. 1994;112:186–90.PubMedCrossRef Schein OD, Buehler PO, Stamler JF, et al. The impact of overnight wear on the risk of contact lens–associated ulcerative keratitis. Arch Ophthalmol. 1994;112:186–90.PubMedCrossRef
70.
go back to reference Schein OD, Glynn RJ, Poggio EC, Microbial Keratitis Study Group, et al. The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. A case-control study. N Engl J Med. 1989;321:773–8.PubMedCrossRef Schein OD, Glynn RJ, Poggio EC, Microbial Keratitis Study Group, et al. The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. A case-control study. N Engl J Med. 1989;321:773–8.PubMedCrossRef
72.
go back to reference Thia ZZ, Ho YT, Shih KC, Tong L. New developments in the management of persistent corneal epithelial defects. Surv Ophthalmol. 2023;68:1093–114.PubMedCrossRef Thia ZZ, Ho YT, Shih KC, Tong L. New developments in the management of persistent corneal epithelial defects. Surv Ophthalmol. 2023;68:1093–114.PubMedCrossRef
73.
go back to reference Lim P, Ridges R, Jacobs DS, Rosenthal P. Treatment of persistent corneal epithelial defect with overnight wear of a prosthetic device for the ocular surface. Am J Ophthalmol. 2013;156:1095–101.PubMedCrossRef Lim P, Ridges R, Jacobs DS, Rosenthal P. Treatment of persistent corneal epithelial defect with overnight wear of a prosthetic device for the ocular surface. Am J Ophthalmol. 2013;156:1095–101.PubMedCrossRef
74.
go back to reference Fonn D, Bruce AS. A review of the Holden–Mertz criteria for critical oxygen transmission. Eye Contact Lens. 2005;31:247–51.PubMedCrossRef Fonn D, Bruce AS. A review of the Holden–Mertz criteria for critical oxygen transmission. Eye Contact Lens. 2005;31:247–51.PubMedCrossRef
75.
go back to reference Flynn CA, D’Amico F, Smith G. Should we patch corneal abrasions? A meta-analysis J Fam Pract. 1998;47:264–70.PubMed Flynn CA, D’Amico F, Smith G. Should we patch corneal abrasions? A meta-analysis J Fam Pract. 1998;47:264–70.PubMed
76.
go back to reference Lim CH, Turner A, Lim BX. Patching for corneal abrasion. Cochrane Database Syst Rev. 2016;26:CD004764. Lim CH, Turner A, Lim BX. Patching for corneal abrasion. Cochrane Database Syst Rev. 2016;26:CD004764.
77.
go back to reference Kjaergaard N, Hein M, Hyttel L, et al. Antibacterial properties of human amnion and chorion in vitro. Eur J Obstet Gynecol Reprod Biol. 2001;94:224–9.PubMedCrossRef Kjaergaard N, Hein M, Hyttel L, et al. Antibacterial properties of human amnion and chorion in vitro. Eur J Obstet Gynecol Reprod Biol. 2001;94:224–9.PubMedCrossRef
78.
go back to reference Jones B, Li C, Park MS, Lerch A, Jacob V, Johnson N, Kuang JQ, Dhall S, Sathyamoorthy M. Comprehensive comparison of amnion stromal cells and chorion stromal cells by RNA-Seq. Int J Mol Sci. 2021;22:1901.PubMedPubMedCentralCrossRef Jones B, Li C, Park MS, Lerch A, Jacob V, Johnson N, Kuang JQ, Dhall S, Sathyamoorthy M. Comprehensive comparison of amnion stromal cells and chorion stromal cells by RNA-Seq. Int J Mol Sci. 2021;22:1901.PubMedPubMedCentralCrossRef
79.
go back to reference Ting DSJ, Henein C, Said DG, et al. Amniotic membrane transplantation for infectious keratitis: a systematic review and meta-analysis. Sci Rep. 2021;11:13007.PubMedPubMedCentralCrossRef Ting DSJ, Henein C, Said DG, et al. Amniotic membrane transplantation for infectious keratitis: a systematic review and meta-analysis. Sci Rep. 2021;11:13007.PubMedPubMedCentralCrossRef
80.
go back to reference Yang MK, Kim MK, Kim DM. Amniotic membrane transplantation for repair of a large intraoperative conjunctival defect during trabeculectomy. Korean J Ophthalmol. 2015;29:73–4.PubMedPubMedCentralCrossRef Yang MK, Kim MK, Kim DM. Amniotic membrane transplantation for repair of a large intraoperative conjunctival defect during trabeculectomy. Korean J Ophthalmol. 2015;29:73–4.PubMedPubMedCentralCrossRef
81.
go back to reference Tsai RJ, Li LM, Chen JK. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med. 2000;13(343):86–93.CrossRef Tsai RJ, Li LM, Chen JK. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med. 2000;13(343):86–93.CrossRef
82.
go back to reference Sheppard JD, Mansur A, Comstock TL, Hovanesian JA. An update on the surgical management of pterygium and the role of loteprednol etabonate ointment. Clin Ophthalmol. 2014;13(8):1105–18.CrossRef Sheppard JD, Mansur A, Comstock TL, Hovanesian JA. An update on the surgical management of pterygium and the role of loteprednol etabonate ointment. Clin Ophthalmol. 2014;13(8):1105–18.CrossRef
83.
go back to reference Rivera-Morales P, Barnard L, Linderman W, Gill M, Diaz V. Surgical time and postoperative symptoms study in pterygium excision and amniotic membrane graft using celularity triple layer dehydrated amniotic membrane. Clin Ophthalmol. 2023;11(17):1967–74.CrossRef Rivera-Morales P, Barnard L, Linderman W, Gill M, Diaz V. Surgical time and postoperative symptoms study in pterygium excision and amniotic membrane graft using celularity triple layer dehydrated amniotic membrane. Clin Ophthalmol. 2023;11(17):1967–74.CrossRef
84.
go back to reference Palamar M, Kaya, E, Egrilmez S et al. Amniotic membrane transplantation in surgical management of ocular surface squamous neoplasias: long-term results. Eye 2014;28, 1131–1135.CrossRef Palamar M, Kaya, E, Egrilmez S et al. Amniotic membrane transplantation in surgical management of ocular surface squamous neoplasias: long-term results. Eye 2014;28, 1131–1135.CrossRef
85.
go back to reference Wu M, Zhang R, Zou Q, Chen Y, Zhou M, Li X, Ran R, Chen Q. Comparison of the Biological Characteristics of Mesenchymal Stem Cells Derived from the Human Placenta and Umbilical Cord. Sci. Rep. 2018;8:1–9. Wu M, Zhang R, Zou Q, Chen Y, Zhou M, Li X, Ran R, Chen Q. Comparison of the Biological Characteristics of Mesenchymal Stem Cells Derived from the Human Placenta and Umbilical Cord. Sci. Rep. 2018;8:1–9.
86.
go back to reference Tighe S, Mead OG, Lee A, Tseng SCG. Basic science review of birth tissue uses in ophthalmology. Taiwan J Ophthalmol. 2020;10:3–12. Tighe S, Mead OG, Lee A, Tseng SCG. Basic science review of birth tissue uses in ophthalmology. Taiwan J Ophthalmol. 2020;10:3–12.
Metadata
Title
Use of an Eyelid Pressure Patch Concomitantly with a Decellularized Dehydrated Amniotic Membrane for Ocular Surface Disease Management
Author
Kyle Linsey
Publication date
03-02-2025
Publisher
Springer Healthcare
Published in
Ophthalmology and Therapy
Print ISSN: 2193-8245
Electronic ISSN: 2193-6528
DOI
https://doi.org/10.1007/s40123-025-01094-2

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more